Cargando…
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
The pandemic of COVID-19 has highlighted the intricate relationship between gut microbiome and overall health. Recent studies have shown that the Firmicutes/Bacteroidetes ratio in the gut microbiome may be linked to various diseases including COVID-19 and type 2 diabetes (T2D). Understanding the lin...
Autores principales: | Petakh, Pavlo, Oksenych, Valentyn, Kamyshnyi, Aleksandr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183625/ https://www.ncbi.nlm.nih.gov/pubmed/37196542 http://dx.doi.org/10.1016/j.biopha.2023.114892 |
Ejemplares similares
-
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023) -
Tyrosine Kinase Inhibitors Target B Lymphocytes
por: Upfold, Nikki Lyn Esnardo, et al.
Publicado: (2023) -
Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022) -
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
por: Petakh, Pavlo, et al.
Publicado: (2023) -
Effects of metformin on the gut microbiota: A systematic review
por: Pavlo Petakh, et al.
Publicado: (2023)